000 | 01990 a2200589 4500 | ||
---|---|---|---|
005 | 20250517152546.0 | ||
264 | 0 | _c20180206 | |
008 | 201802s 0 0 eng d | ||
022 | _a1464-0619 | ||
024 | 7 |
_a10.1080/13546805.2017.1322502 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpellmann, Ilja | |
245 | 0 | 0 |
_aAssociations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment. _h[electronic resource] |
260 |
_bCognitive neuropsychiatry _cJul 2017 |
||
300 |
_a280-297 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBasic Helix-Loop-Helix Transcription Factors _xgenetics |
650 | 0 | 4 |
_aCognition _xphysiology |
650 | 0 | 4 |
_aCognition Disorders _xgenetics |
650 | 0 | 4 |
_aExecutive Function _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory _xphysiology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeuropeptides _xgenetics |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
650 | 0 | 4 | _aReaction Time |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 | _aSchizophrenic Psychology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aRiedel, Michael | |
700 | 1 | _aStädtler, Julia | |
700 | 1 | _aZill, Peter | |
700 | 1 | _aObermeier, Michael | |
700 | 1 | _aCerovecki, Anja | |
700 | 1 | _aDehning, Sandra | |
700 | 1 | _aSchennach, Rebecca | |
700 | 1 | _aEpple, Maria | |
700 | 1 | _aOpgen-Rhein, Markus | |
700 | 1 | _aMüller, Norbert | |
700 | 1 | _aBondy, Brigitta | |
700 | 1 | _aMöller, Hans-Jürgen | |
700 | 1 | _aMusil, Richard | |
773 | 0 |
_tCognitive neuropsychiatry _gvol. 22 _gno. 4 _gp. 280-297 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/13546805.2017.1322502 _zAvailable from publisher's website |
999 |
_c27139932 _d27139932 |